Poland· PL-100016386
Cyclonamine
A etamsylate product containing etamsylatum, registered in Poland by Farmaceutyczna Spółdzielnia Pracy GALENA. The same ATC class is registered in 6 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Etamsylate is registered in 6 of 19 countries.
Countries holding a registration under ATC B02BX01 (etamsylate), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Etamsylate · ATC B02BX01
6 / 19 countries
- Belgiumprice
- Czechiaprice
- Franceprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Etamsylatum
- Manufacturer
- Farmaceutyczna Spółdzielnia Pracy GALENA
- Country
- Poland (PL)
- ATC code
- B02BX01
- ATC class
- Etamsylate
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990046416
- gtin05909991431242
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Etamsylate in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceDICYNONE 250 mg, compriméOMEDICAMED UNIPESSOAL (PORTUGAL)
- CzechiaCYCLONAMINEFarmaceutyczna Spółdzielnia Pracy Galena, Wrocław
- United KingdomDicynene 250mg/2ml solution for injection ampoulesSanofi-Synthelabo Ltd
- SwitzerlandDicynone
- FinlandHemosilate VetEcuphar Veterinaria S.L.U.
- BelgiumDicynone 250 mgOMEDICAMED Unipessoal
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Belgium · Dicynone
- Bulgaria · Дицинон, Циклонамин
- Czechia · Cyclonamine, Dicynone 250
- France · Dicynone
- Hungary · Dicynone
- Lithuania · Dicynone
- Luxembourg · Dicynone®
- Latvia · Dicynone
- Romania · Etamsilat Zentiva
- Slovenia · Dicynone
- Slovakia · Cyclonamine, Dicynone 500
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/08aca15f-261f-4d9c-96bc-9386d16dccf0 GET /v1/drugs/08aca15f-261f-4d9c-96bc-9386d16dccf0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "250 mg",
"packaging": "05909990046416 ¦ Rp ¦ 44262\n30 tabl.\n05909991431242 ¦ Rp ¦ 136530\n60 tabl.",
"substance": "Etamsylatum 250 mg",
"common_name": "Etamsylatum",
"pl_product_id": "100016386",
"pozwolenie_nr": "00464",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about etamsylate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.